CLPT
CLPT
NASDAQ · Health Care

Clearpoint Neuro Inc

$7.82
-0.04 (-0.51%)
As of Nov 18, 8:20 PM ET ·
Financial Highlights (FY 2026)
Revenue
42.17M
Net Income
-29,134,306
Gross Margin
61.4%
Profit Margin
-69.1%
Rev Growth
+21.6%
D/E Ratio
1.75
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 61.4% 61.4% 53.8% 53.8%
Operating Margin -65.4% -58.8% 16.4% 17.6%
Profit Margin -69.1% -65.6% 15.4% 15.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 42.17M 34.68M 158.88M 142.75M
Gross Profit 25.89M 21.28M 85.53M 76.84M
Operating Income -27,564,720 -20,398,164 26.07M 25.18M
Net Income -29,134,306 -21,559,673 24.47M 21.58M
Gross Margin 61.4% 61.4% 53.8% 53.8%
Operating Margin -65.4% -58.8% 16.4% 17.6%
Profit Margin -69.1% -65.6% 15.4% 15.1%
Rev Growth +21.6% +21.6% +20.9% +17.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 87.28M 87.28M 75.59M 72.54M
Total Equity 49.83M 49.83M 144.13M 160.68M
D/E Ratio 1.75 1.75 0.52 0.45
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -27,487,023 -21,470,705 37.89M 33.02M
Free Cash Flow — — 31.87M 21.95M